Influence of diabetes mellitus in patients with long coronary lesions undergoing percutaneous coronary interventions: multicenter registry in Japan

被引：0
作者：
Nakamura, S.
Sato, H.
Hirashima, O.
Kurita, N.
Hirose, M.
Hozawa, K.
Nakamura, S.
Koyama, J.
机构：
[1] New Tokyo Hosp, Dept Cardiol, Matsudo, Chiba, Japan
[2] Chiba Cent Med Ctr, Dept Cardiol, Chiba, Japan
[3] Secomed Hosp, Dept Cardiol, Funabashi, Chiba, Japan
来源：
EUROPEAN HEART JOURNAL | 2005年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：494 / 494
页数：1
相关论文
共 50 条
[31]   Cardiorenal protection with dapagliflozin in patients with type 2 diabetes mellitus and chronic coronary syndrome undergoing percutaneous coronary intervention: a registry cross-sectional study [J].
Zinan Zhao ;
Naixin Zheng ;
Tianqi Zhang ;
Chi Zhang ;
Yuwei Li ;
Ming Lan ;
Ni Zhang ;
Hui Li ;
Hu Ai ;
Deping Liu .
Cardiovascular Diabetology, 24 (1)
[32]   Prevalence of diabetes mellitus (known and unknow) and pre-diabetes in patients undergoing percutaneous coronary intervention [J].
Delgado, Elias ;
De La Hera, Jesus M. ;
Botas, Patricia ;
Garcia, Jose M. ;
Hernandez, Ernesto ;
Lozano, Inigo ;
Avanzas, Pablo ;
Moris, Cesar .
DIABETES, 2007, 56 :A171-A172
[33]   Comparative efficacy of ticagrelor in patients with coronary artery disease and type 2 diabetes mellitus after percutaneous coronary interventions [J].
Orziev, D. ;
Abdullaev, A. ;
Alyavi, B. ;
Uzokov, J. ;
Mukhitdinova, O. .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2023, 53
[34]   Optimization of antiplatelet therapy in patients with coronary artery disease and type 2 diabetes mellitus after percutaneous coronary interventions [J].
Mukhamedova, M. ;
Orziev, D. Z. ;
Uzokov, J. K. ;
Abdullaev, A. X. .
EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2023, 22 :I44-I44
[35]   The impact of complete revascularization on long-term outcomes in patients complicated with diabetes mellitus undergoing percutaneous coronary intervention [J].
Ando, K. ;
Yamada, T. ;
Shirai, S. ;
Iwabuchi, M. ;
Yokoi, H. ;
Yasumoto, H. ;
Nosaka, H. ;
Nobuyoshi, M. .
EUROPEAN HEART JOURNAL, 2006, 27 :600-600
[36]   Abciximab as an adjunctive therapy for patients undergoing percutaneous coronary interventions [J].
Parikh, Devang ;
Juergens, Craig P. .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2011, 11 (02) :235-246
[37]   Impact of diabetes mellitus on long term clinical outcome in patients with acute myocardial infarction undergoing percutaneous coronary intervention [J].
Kim, J. J. ;
Choi, I. K. ;
Choi, E. H. ;
Kim, J. G. ;
Moon, D. G. ;
Kang, M. K. ;
Lee, J. M. ;
Shin, D. I. ;
Kim, C. J. ;
Seung, K. B. .
EUROPEAN HEART JOURNAL, 2013, 34 :562-562
[38]   Optimal timing for percutaneous coronary interventions in patients undergoing TAVI [J].
Venturi, Gabriele ;
Lunardi, Mattia ;
Del Sole, Paolo Alberto ;
Pighi, Michele ;
Scarsini, Roberto ;
Ribichini, Flavio .
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)
[39]   Predictors of stroke in patients undergoing percutaneous coronary interventions. [J].
Hajj-Ali, R ;
Ezzeddine, R ;
Park, C ;
Katz, S ;
Kaplan, B ;
Marchant, D ;
Green, S ;
Ong, L .
AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (5A) :42G-42G
[40]   Pharmacogenetics and Clopidogrel Response in Patients Undergoing Percutaneous Coronary Interventions [J].
Beitelshees, A. L. ;
Horenstein, R. B. ;
Vesely, M. R. ;
Mehra, M. R. ;
Shuldiner, A. R. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (03) :455-459
12345